Micromet Inc. Company Profile

18:51 EST 10th December 2018 | BioPortfolio

Micromet, Inc. (NASDAQ: MITI) is a transatlantic biopharmaceutical company formed through the mergerof Micromet AG and CancerVax, Inc. in May 2006.Focused on the development and design of novel antibody derived drugs, the Company has built a wellstaged pipeline of highly differentiated products for the treatment of cancer, inflammation and autoimmune diseases. Micromet´s strong pipeline-generating and evelopmental capabilities have enabled the Company to pursue a growth-oriented business strategy and to generate ignificant revenues through partnerships with companies like Serono and MedImmune, Inc. In parallel,Micromet has consolidated key intellectual property in the antibody sector, secured a strong IP osition on its candidates and technologies and established an active out-licensing business for single-chain antibody technology.


2110 Rutherford Road
United States of America


Phone: (760) / 494-4200
Fax: (760) / 431-9980

News Articles [4 Associated News Articles listed on BioPortfolio]

Micromet: From Europe to the US: The Transformation of Micromet

In this interview, Fintan Walton talks to Christian Itin, President and CEO of antibody technology company Micromet. Christian talks about how the company was set up in Munich to address one of the ga...

R&D Deal, PTV News: May 06, 2010

Boehringer Ingelheim and Micromet collaborate on R&D and commercialisation of cancer therapy

News Headlines, PTV News: May 06, 2010

A look at today's forthcoming news stories: Merck & Co restructures deal with Ariad to take control of sarcoma therapy; Boehringer Ingelheim and Micromet to collaborate on R&D for multiple myeloma, an...

PTV News: Oct 29, 2009

Top stories on October 29th, 2009: Emerging markets and swine flu ramp GSK profits Sanofi's cancer deal with Micromet Vertex Hep C drug boasts impressive trial results Tysabri test for PML risk ...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]

Micromet, Inc.

Micromet, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibody-based therapies for the treatment of cancer. Its product development pi...

Micromet Inc.

Micromet, Inc. (NASDAQ: MITI) is a transatlantic biopharmaceutical company formed through the mergerof Micromet AG and CancerVax, Inc. in May 2006.Focused on the development and design of novel antibo...

More Information about "Micromet Inc." on BioPortfolio

We have published hundreds of Micromet Inc. news stories on BioPortfolio along with dozens of Micromet Inc. Clinical Trials and PubMed Articles about Micromet Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Micromet Inc. Companies in our database. You can also find out about relevant Micromet Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Corporate Database Quicklinks

Searches Linking to this Company Record